Learn

The resurgence in invasive pneumococcal disease is driving rising hospitalisations and preventable morbidity in infants and young children. Despite improved vaccine access and higher-valent options, many children remain under-protected.

Led by an expert faculty, this CPD-accredited session will clarify current vaccine recommendations, identify who remains at risk, and provide simple, repeatable strategies to support earlier protection. With a strong focus on real-world application, the session will utilise practical strategies, engaging presentations and interactive Q&A to support clinicians to translate vaccine availability into consistent delivery in practice, reducing missed opportunities and improving timely protection.

Learning Outcomes

1. Quantify how many children remain at preventable risk of pneumococcal disease by understanding current incidence trends, coverage gaps, and the consequences of delayed or missed vaccination
2. Recognise the clinical indicators and at-risk groups that heighten vulnerability to severe pneumococcal disease among infants and young children
3. Apply current paediatric pneumococcal vaccination recommendations with confidence, including NIP updates, higher-valent vaccine options, and pathways for protecting medically at-risk children
4. Communicate pneumococcal risk effectively to parents and caregivers, using clear, practical, and evidence-aligned messaging that supports timely vaccination decisions
5. Implement simple, scalable workflow strategies that enable consistent identification, recall, and opportunistic vaccination of eligible children within everyday practice.

Details